Australia's most trusted
source of pharma news
Posted 16 November 2023 PM
Health Minister Mark Butler has announced the first December PBS listing, 15 days early and in time for Christmas with the expansion of Bayer's Nubeqa for men with prostate cancer.
It's the first and only medicine specifically registered by the TGA for use in triple therapy to fight cancer in a number of different and complementary ways as soon as it has escaped the prostate.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.